{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-029243","form_type":"8-K","ticker":"QCLS","cik":"0001321834","company_name":"Q/C TECHNOLOGIES, INC.","filed_at":"2024-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.585459+00:00","generated_at":"2026-05-31T15:56:02.791581+00:00","sec_items":["3.03","5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"TNF Pharmaceuticals shareholders approve 15x increase in authorized common stock to 250M shares","bullets":["Authorized common shares increased from 16,666,666 to 250,000,000; amendment filed July 25, 2024.","Shareholders also approved issuance of shares underlying Series F-1 and G Preferred and warrants for Nasdaq Rule 5635 compliance.","Share Increase Proposal vote: 819,760 for, 73,259 against, 12,851 abstain.","Ratification of Morison Cogen as independent auditor for FY2024 passed with 1,536,758 votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-029243","json":"https://secwatch.observer/filing/0001493152-24-029243.json","markdown":"https://secwatch.observer/filing/0001493152-24-029243.md","text":"https://secwatch.observer/filing/0001493152-24-029243.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224029243/0001493152-24-029243-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224029243/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:56:02.791581+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}